Inovio Pharmaceuticals Inc. stock underperforms Friday when compared to competitors
This was the stock's second consecutive day of losses.
Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors
Shares of Inovio Pharmaceuticals Inc. INO slipped 1.96% to $2.00 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index COMP rising ...
ETF Daily News28d
Inovio Pharmaceuticals (NASDAQ:INO) Receives Market Outperform Rating from JMP Securities
Inovio Pharmaceuticals (NASDAQ:INO – Get Free Report) ‘s stock had its “market outperform” rating restated by JMP Securities in a report issued on Friday,Benzinga reports.They currently ...
ETF Daily News27d
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Receives $11.50 Average Target Price from Analysts
Shares of NASDAQ INO opened at $1.98 on Friday. The company has a market capitalization of $51.68 million, a PE ratio of -0.95 and a beta of 0.84. Inovio Pharmaceuticals has a twelve month low of ...
Inovalis REIT Achieves Its First LEED Platinum Certification in Spain
Inovalis Real Estate Investment Trust (the "REIT") (TSX: INO.UN) announced its first LEED Platinum certification for the ...
Investing29d
Inovio Pharmaceuticals' SWOT analysis: dna-based immunotherapy firm faces hurdles
The company plans to present immunological data supporting INO-3107 at upcoming international conferences, which could provide insights into the therapy's mechanism of action and long-term efficacy.
tom's Hardware on MSN12d
Nvidia loses $589 billion in market cap — broad stock plunge triggered by DeepSeek AI release
Nvidia stock prices plummet by 17% after the release of DeepSeek. Investors nervous that investing in more hardware is unnecessary to develop advanced AI.